Analyst Ratings for Stealth BioTherapeutics (MITO)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/1/2021 | Maxim Group | Jason McCarthy | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.56 (0.32) |
-79.49% | Details |
| 4/14/2020 | Roth/MKM | Yasmeen Rahimi | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.59 (0.32) |
-79.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
